Additionally, the upregulation of PSMB8 in cancer appeared to occur through a cell-intrinsic mechanism, being more prevalent in the AML–M5 subtype, which frequently harbors myeloid/lymphoid or mixed-lineage leukemia (MLL) fusions [72]. Here, KMT2A is linked to cancer.